Duloxetine
- Product NDC
- 50268-269
- 11-digit product format
- 502680269
- Labeler code
- 50268
- Product ID
- 50268-269_dfd69774-f807-f9ba-e053-2a95a90a7cab
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Duloxetine
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA204343
- Marketing category
- ANDA
- Marketing start
- 2022-05-18
- Marketing end
- 0000-00-00
- Substance
- DULOXETINE HYDROCHLORIDE
- Active strength
- 20 mg/1
- Pharmacologic classes
- Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-269-15 | 50268026915 | 50 BLISTER PACK in 1 BOX (50268-269-15) > 1 CAPSULE, DELAYED RELEASE in 1 BLISTER PACK (50268-269-11) | 50 blister pack | 2022-05-18 | 0000-00-00 | No | No | Current |